XWELL Announces Plan for Strategic Investment in Medical Spas to Advance Wellness and Beauty Offerings
March 13 2025 - 8:00AM
XWELL, Inc. (Nasdaq: XWEL) ("XWELL" or the "Company"), a pioneer in
democratizing wellness, today announced plans to acquire select
medical spas by the end of 2025, leveraging its recent $4 million
private placement to expand into the high-growth wellness and
beauty sector. This strategic move aligns with XWELL’s mission to
“liberate wellness” by creating a seamless continuum of care,
extending beyond airports and into metropolitan areas where demand
for advanced beauty and wellness treatments is rising.
“The intersection of wellness and beauty is transforming the
industry, and XWELL is poised to lead this evolution,” said XWELL
CEO Ezra Ernst. “By acquiring and enhancing medical spas, we’re not
only investing in a rapidly growing market but also ensuring that
consumers have access to high-quality, science-backed wellness
experiences. This expansion is a pivotal step in our vision to
become the go-to nationwide brand for holistic self-care.”
XWELL will initially focus on select metropolitan areas with
strong demand for medspa services, including Orlando, Austin,
Texas, and Salt Lake City. Through these acquisitions, the Company
aims to introduce state-of-the-art treatments, AI-driven
personalization and innovative skincare solutions that align with
today’s evolving wellness needs.
The global medical spa market is rapidly expanding as consumers
increasingly seek non-invasive, results-driven treatments that
enhance beauty, wellness and overall quality of life. XWELL’s
approach will blend luxury with medical expertise and will offer a
curated selection of high-impact treatments administered by
certified professionals, which may include:
- Facial Aesthetics & Skin
Care Treatments – Customized facials, chemical peels,
and microneedling to rejuvenate skin and improve complexion.
- Injectables &
Fillers – Botox, Dysport, and dermal fillers to
address fine lines, wrinkles, volume loss, and facial contouring
for a natural, youthful appearance.
- Body Sculpting –
Non-invasive treatments such as CoolSculpting and radiofrequency
skin tightening, helping clients achieve their desired body shape
without the need for surgery.
- Laser Therapies –
State-of-the-art laser treatments for skin resurfacing, hair
removal, and pigmentation correction, ensuring clients receive safe
and effective results.
- Massage & Relaxation
Therapies – A variety of therapeutic massages to
improve circulation, reduce stress, and promote relaxation and
wellness.
- Wellness and Recovery
Services – Including IV hydration therapy, vitamin
shots, and other restorative treatments to help clients optimize
their health and well-being.
- Weight Loss Management
– Achieve weight loss goals with physician-guided treatments,
including FDA-approved medications designed to support safe and
effective results. Personalized plans help optimize appetite
control, metabolism, and overall wellness.
This move is part of XWELL’s long-term strategy to establish a
nationwide presence in beauty and wellness, delivering cutting-edge
self-care solutions that prioritize health, confidence, and
well-being.
For more information on XWELL’s offerings, visit
www.XWELL.com.
About XWELL, Inc.XWELL, Inc. (Nasdaq: XWEL) is
a leading global wellness holding company operating multiple
brands: XWELL™, Xpres Spa®, Treat™, Naples Wax Center®, XpresCheck®
and HyperPointe™.
- Xpres Spa is a leading retailer of wellness services and
related products.
- Naples Wax Center is a group of upscale skin care
boutiques.
- XpresCheck, in partnership with the CDC and Ginkgo Biosecurity,
conducts biosurveillance monitoring in its airport locations.
- HyperPointe is a leading digital healthcare and data analytics
relationship company serving the global healthcare industry.
Forward-Looking StatementsThis press release
may contain "forward-looking" statements within the meaning of the
Private Securities Litigation Reform Act of 1995, Section 27A of
the Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended. These include
statements preceded by, followed by or that otherwise include the
words "believes," "expects," "anticipates," "estimates,"
"projects," "intends," "should," "seeks," "future," "continue," or
the negative of such terms, or other comparable terminology.
Important factors that could cause actual results to differ
materially from those indicated by such forward-looking statements
include, without limitation: the anticipated use of proceeds from
the private placement. Forward-looking statements relating to
expectations about future results or events are based upon
information available to XWELL as of the date of this press
release, and are not guarantees of the future performance of the
Company, and actual results may vary materially from the results
and expectations discussed. Additional information concerning these
and other risks is contained in the Company’s Annual Report on Form
10-K, as amended, Quarterly Reports on Form 10-Q and Current
Reports on Form 8-K, and other Securities and Exchange
Commission filings. All subsequent written and oral forward-looking
statements concerning XWELL, or other matters and attributable to
XWELL or any person acting on its behalf are expressly qualified in
their entirety by the cautionary statements above. XWELL does not
undertake any obligation to publicly update any of these
forward-looking statements to reflect events or circumstances that
may arise after the date hereof.
Media
Valentina Marmolejo
MWW
vmarmolejo@mww.com
XWELL (NASDAQ:XWEL)
Historical Stock Chart
From Apr 2025 to May 2025
XWELL (NASDAQ:XWEL)
Historical Stock Chart
From May 2024 to May 2025